...
首页> 外文期刊>PLOS Neglected Tropical Diseases >High Content Screening of a Kinase-Focused Library Reveals Compounds Broadly-Active against Dengue Viruses
【24h】

High Content Screening of a Kinase-Focused Library Reveals Compounds Broadly-Active against Dengue Viruses

机译:对激酶库的高内涵筛选揭示了对登革热病毒具有广泛活性的化合物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Dengue virus is a mosquito-borne flavivirus that has a large impact in global health. It is considered as one of the medically important arboviruses, and developing a preventive or therapeutic solution remains a top priority in the medical and scientific community. Drug discovery programs for potential dengue antivirals have increased dramatically over the last decade, largely in part to the introduction of high-throughput assays. In this study, we have developed an image-based dengue high-throughput/high-content assay (HT/HCA) using an innovative computer vision approach to screen a kinase-focused library for anti-dengue compounds. Using this dengue HT/HCA, we identified a group of compounds with a 4-(1-aminoethyl)-N-methylthiazol-2-amine as a common core structure that inhibits dengue viral infection in a human liver-derived cell line (Huh-7.5 cells). Compounds CND1201, CND1203 and CND1243 exhibited strong antiviral activities against all four dengue serotypes. Plaque reduction and time-of-addition assays suggests that these compounds interfere with the late stage of viral infection cycle. These findings demonstrate that our image-based dengue HT/HCA is a reliable tool that can be used to screen various chemical libraries for potential dengue antiviral candidates.
机译:登革热病毒是一种蚊子传播的黄病毒,对全球健康具有重大影响。它被认为是医学上重要的虫媒病毒之一,开发预防或治疗解决方案仍然是医学和科学界的头等大事。在过去的十年中,针对潜在登革热抗病毒药物的药物发现计划已大大增加,部分原因是采用了高通量检测方法。在这项研究中,我们使用创新的计算机视觉方法开发了基于图像的登革热高通量/高含量检测(HT / HCA),以筛选针对激酶的抗登革热化合物文库。使用这种登革热HT / HCA,我们鉴定了一组具有4-(1-氨基乙基)-N-甲基噻唑-2-胺的化合物,它们是抑制人肝源性细胞系中登革热病毒感染的共同核心结构(Huh -7.5个单元格)。化合物CND1201,CND1203和CND1243对所有四种登革热血清型均表现出强大的抗病毒活性。噬菌斑减少和添加时间测定表明这些化合物干扰病毒感染周期的后期。这些发现表明,我们基于图像的登革热HT / HCA是可靠的工具,可用于筛选各种化学文库中潜在的登革热抗病毒候选药物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号